Gwajin gaggawa na SARS-CoV-2 IgM/IgG Antibody
Mataki mai ƙarfi®Gwajin gaggawa na SARS-CoV-2 IgG/IgM Antibody
Hakanan za su iya gano ko sun riga sun kamu da kwayar cutar ta SARS-CoV-2 kuma sun murmure. Wannan gwajin an ba shi izini kawai don gano ƙwayoyin rigakafi na SARS-CoV-2 takamaiman IgM da IgG. IgG da lgM rigakafi zuwa 2019 Novel Coronavirus na iya zama. gano tare da 2-3 makonni bayan bayyanar.Sakamako mara kyau baya hana kamuwa da cutar SARS-CoV-2 mai tsanani.Kyakkyawan sakamako na iya kasancewa saboda kamuwa da cuta na baya ko na yanzu tare da nau'ikan coronavirus marasa SARS-CoV-2, kamar coronavirus HKU1, NL63, OC43, ko 229E.lgG ya kasance tabbatacce, amma matakin antibody yana raguwa akan kari.Bai dace da wasu ƙwayoyin cuta ko ƙwayoyin cuta ba, kuma bai kamata a yi amfani da sakamakon don tantance ko kawar da kamuwa da cutar ta SARS-CoV ko sanar da matsayin kamuwa da cuta ba.
Idan ana zargin kamuwa da cuta mai tsanani, gwajin kai tsaye don SARS-CoV-2 ya zama dole.
AMFANI DA NUFIN
Matakin Karfi®Gwajin SARS-CoV-2 IgM/IgG shine saurin gwajin immuno-chromatographic don gano lokaci guda na rigakafin IgM da IgG zuwa kwayar cutar SARS-CoV-2 a cikin jinin mutum gaba daya, ruwan magani ko plasma.Ana amfani da gwajin azaman taimako don gano cutar ta COVID-19.
GABATARWA
Coronavirus an lullube kwayar cutar ta RNA wacce aka rarraba a tsakanin mutane, sauran dabbobi masu shayarwa da tsuntsaye, wadanda ke haifar da cututtukan numfashi, ciki, hanta da cututtukan neurologic.An san nau'ikan coronavirus bakwai suna haifar da cutar ɗan adam.Nau'o'in ƙwayoyin cuta guda huɗu - 229E, OC43, NL63 da HKU1 - suna da yawa kuma galibi suna haifar da alamun mura na gama gari a cikin mutane masu ƙarfin rigakafi.Sauran nau'ikan nau'ikan guda uku - mummunan cututtukan numfashi na coronavirus (SARS-CoV), coronavirus na numfashi na Gabas ta Tsakiya (MERS-CoV) da 2019 Novel Coronavirus (COVID-19) - asalin zoonotic ne kuma ana danganta su da rashin lafiya wani lokaci, Coronavirus. zoonotic ne, wanda ke nufin ana iya yada su tsakanin dabbobi da mutane.Alamomin kamuwa da cuta na yau da kullun sun haɗa da alamun numfashi, zazzabi, tari, ƙarancin numfashi da wahalar numfashi.A lokuta masu tsanani, kamuwa da cuta na iya haifar da ciwon huhu, matsanancin ciwo na numfashi, gazawar koda har ma da mutuwa.IgM da IgG rigakafi zuwa 2019 Novel Coronavirus za a iya gano shi tare da makonni 1-2 bayan fallasa.IgG ya kasance tabbatacce, amma matakin antibody yana raguwa akan kari.
KA'IDA
Matakin Karfi®Gwajin SARS-CoV-2 IgM/IgG yana amfani da ƙa'idar Immuno-chromatography.Kowace na'ura tana ɗauke da tsiri guda biyu, inda SARS-CoV-2 takamaiman antigen recombinant ke motsawa akan membrane na nitrocellulose a cikin taga gwajin na'urar.Mouse anti-human IgM da anti-an adam IgG rigakafi haɗe tare da launi latex beads ba su motsi a kan conjugate pad na biyu tube bi da bi.Yayin da samfurin gwajin ke gudana ta cikin membrane a cikin na'urar gwajin, linzamin kwamfuta mai launin IgM da anti-antibodies IgG suna haifar da hadaddun haɗin gwiwar latex tare da ƙwayoyin rigakafi na ɗan adam (IgM da/ko IgG).Wannan hadaddun yana motsawa gaba akan membrane zuwa yankin gwaji inda SARS-CoV-2 takamaiman antigen ta sake kama shi.Idan SARS-CoV-2 ƙwayoyin rigakafi IgG/IgM suna cikin samfurin, wanda ke haifar da samuwar band mai launi kuma yana nuna sakamako mai kyau na gwaji.Rashin wannan makada mai launi a cikin taga gwajin yana nuna mummunan sakamakon gwaji.Wannan hadaddun yana ci gaba da tafiya akan membrane zuwa yankin sarrafawa inda aka kama shi ta hanyar anti-mouse antibody kuma ya samar da layin sarrafawa na ja wanda yake ginannen layin sarrafawa wanda koyaushe zai bayyana a cikin taga gwajin da kyau, ba tare da la'akari ba. na kasancewar ko rashi na anti-SARS-CoV-2 ƙwayoyin rigakafin ƙwayoyin cuta a cikin samfurin.
KIT ABUBUWAN
1. Mataki mai ƙarfi®Katin Gwajin SARS-CoV-2 IgM/IgG a cikin jakar foil
2. Samfurin Buffer
3. Umarni don Amfani
KAYAN DA AKE BUKATA AMMA BA'A SAMU BA
1. Kwandon tarin Sepcimen
2. 1-20μL Pipetter
3. Mai ƙidayar lokaci
Gwajin yana iyakance a cikin Amurka don rarrabawa zuwa dakunan gwaje-gwaje da CLIA ta tabbatar don yin babban gwaji mai rikitarwa.
FDA ba ta sake duba wannan gwajin ba.
Sakamako mara kyau baya hana kamuwa da cutar SARS-CoV-2 mai tsanani.
Idan ana zargin kamuwa da cuta mai tsanani, gwajin kai tsaye don SARS-CoV-2 ya zama dole.
Sakamakon gwajin rigakafin mutum bai kamata a yi amfani da shi ba don tantancewa ko keɓe kamuwa da cutar SARS-CoV-2 mai tsanani.
Kyakkyawan sakamako na iya kasancewa saboda kamuwa da cuta na baya ko na yanzu tare da nau'ikan coronavirus marasa SARS-CoV-2, kamar coronavirus HKU1, NL63, OC43, ko 229E.
